Covered recipient · General Payments record
KYLIE KOFLER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$1,395.49
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,395.49 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $495.65 | 18 |
| Arcutis Biotherapeutics, Inc. | $182.13 | 2 |
| E.R. Squibb & Sons, L.L.C. | $171.71 | 3 |
| LEO Pharma Inc. | $163.26 | 3 |
| Dermavant Sciences, Inc. | $141.62 | 1 |
| Galderma Laboratories, L.P. | $96.09 | 1 |
| Lilly USA, LLC | $53.77 | 2 |
| Regeneron Healthcare Solutions, Inc. | $36.05 | 1 |
| GENZYME CORPORATION | $22.17 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.76 | 1 |
| PFIZER INC. | $13.28 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $1,395.49 | 34 |
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.81 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478770 | CMS |
| ABBVIE INC. | $5.18 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478772 | CMS |
| ABBVIE INC. | $113.53 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478774 | CMS |
| ABBVIE INC. | $26.77 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478776 | CMS |
| ABBVIE INC. | $12.99 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478778 | CMS |
| ABBVIE INC. | $20.52 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478780 | CMS |
| ABBVIE INC. | $26.64 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478782 | CMS |
| ABBVIE INC. | $5.39 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478784 | CMS |
| ABBVIE INC. | $15.36 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478786 | CMS |
| ABBVIE INC. | $8.56 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478788 | CMS |
| ABBVIE INC. | $8.10 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478790 | CMS |
| ABBVIE INC. | $34.35 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478792 | CMS |
| ABBVIE INC. | $6.21 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478794 | CMS |
| ABBVIE INC. | $8.57 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478796 | CMS |
| ABBVIE INC. | $9.05 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478798 | CMS |
| ABBVIE INC. | $130.77 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478800 | CMS |
| ABBVIE INC. | $23.60 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478802 | CMS |
| ABBVIE INC. | $14.25 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107478804 | CMS |
| Arcutis Biotherapeutics, Inc. | $23.55 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121106916 | CMS |
| Arcutis Biotherapeutics, Inc. | $158.58 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121106918 | CMS |
| Dermavant Sciences, Inc. | $141.62 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127987841 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.36 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101502193 | CMS |
| E.R. Squibb & Sons, L.L.C. | $134.38 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101502208 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.97 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101502204 | CMS |
| Galderma Laboratories, L.P. | $96.09 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145369417 | CMS |
| GENZYME CORPORATION | $22.17 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139994297 | CMS |
| LEO Pharma Inc. | $13.31 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152675171 | CMS |
| LEO Pharma Inc. | $17.10 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152675173 | CMS |
| LEO Pharma Inc. | $132.85 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152675175 | CMS |
| Lilly USA, LLC | $20.16 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135750525 | CMS |
| Lilly USA, LLC | $33.61 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135785162 | CMS |
| Novartis Pharmaceuticals Corporation | $19.76 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087147762 | CMS |
| PFIZER INC. | $13.28 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131457486 | CMS |
| Regeneron Healthcare Solutions, Inc. | $36.05 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114327701 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.